Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Labussière, Hélène  [Clear All Filters]
2023
Cannas G, Poutrel S, Heiblig M, Labussière H, Larcher M-V, Thomas X, Hot A. Sickle cell disease and acute leukemia: one case report and an extensive review. Ann Hematol. 2023.
2021
Plesa A, Roumier C, Gutrin J, Larcher M-V, Balsat M, Cadassou O, Barraco F, Fossard G, Baudouin A, Labussière H, et al. Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometry. Leuk Res. 2021;111:106673.
2019
Fayard A, Daguenet E, Blaise D, Chevallier P, Labussière H, Berceanu A, Yakoub-Agha I, Socié G, Charbonnier A, Suarez F, et al. Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell. Bone Marrow Transplant. 2019.
2016
Michallet M, Sobh M, Labussière H, Lombard C, Barraco F, El-Hamri M, Thomas X, Chapuis-Cellier C, Nicolini FE. Potential anti-leukemic activity of iron chelation after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. Leuk Lymphoma. 2016:1-4.
2014
Michallet M, Sobh M, Serrier C, Morisset S, Labussière H, Ducastelle S, Barraco F, Gilis L, Thomas X, Nicolini FE. Allogeneic hematopoietic stem cell transplantation for hematological malignancies from mismatched 9/10 HLA unrelated donors: Comparison with transplantations from 10/10 unrelated donors and HLA identical siblings. Leuk Lymphoma. 2014:1-16.
2013
Plesa A, Chelghoum Y, Mattei E, Labussière H, Elhamri M, Cannas G, Morisset S, Tagoug I, Michallet M, Dumontet C, et al. Mobilization of CD34(+)CD38(-) hematopoietic stem cells after priming in acute myeloid leukemia. World J Stem Cells. 2013;5(4):196-204.